BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Clin Oncol. Nov 24, 2025; 16(11): 112212
Published online Nov 24, 2025. doi: 10.5306/wjco.v16.i11.112212
Figure 1
Figure 1 Patient screening flowchart. HCC: Hepatocellular carcinoma; ECOG: Eastern Cooperative Oncology Group; SR: Surgical resection; TA: Thermal ablation.
Figure 2
Figure 2 Kaplan-Meier curves for overall survival and recurrence-free survival in the surgical resection and thermal ablation groups. A: Overall survival; B: Recurrence-free survival. OS: Overall survival; RFS: Recurrence-free survival.
Figure 3
Figure 3 Multivariable Cox regression forest plots for overall survival and recurrence-free survival (thermal ablation as reference). A: Overall survival; B: Recurrence-free survival. OS: Overall survival; TA: Thermal ablation; RFS: Recurrence-free survival; AFP: Alpha-fetoprotein; AIC: Akaike information criterion.
Figure 4
Figure 4 Subgroup analysis of overall survival and recurrence-free survival. A: Overall survival for patients aged ≤ 60 years; B: Recurrence-free survival for patients aged ≤ 60 years; C: Overall survival for patients aged > 60 years; D: Recurrence-free survival for patients aged > 60 years. OS: Overall survival; RFS: Recurrence-free survival.